| Financial Year |
March 31 2023 |
| Monetary Funds |
2,360,664,351.11 |
| Held-for-trading Financial Assets |
251,458,333.33 |
| Notes Receivable |
111,286,414.19 |
| Accounts Receivable |
5,108,870,552.75 |
| Advances to Suppliers |
280,104,600.92 |
| Other Receivables |
219,242,225.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,768,624,254.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,044,269.44 |
| Other Current Assets |
1,090,792,461.19 |
| Total Current Assets |
13,683,236,514.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,236,734,195.57 |
| Investment Properties |
55,081,879.69 |
| Fixed Assetes |
3,583,536,284.58 |
| Under-construction Projects |
856,992,684.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
475,314,532.11 |
| R&D expenses |
-- |
| Goodwill |
835,677,495.53 |
| Long-Term Deferred and Prepaid Expenses |
668,105,657.26 |
| Deferred Income Tax Assets |
359,669,764.35 |
| Other Non-Current Assets |
75,050,571.20 |
| Sub-Total of Non-Current Assets |
9,797,993,339.26 |
| Total Assets |
23,481,229,853.55 |
| Short-Term Loans |
982,456,571.94 |
| Trading Financial liabilities |
5,794,804.17 |
| Notes Payable |
1,929,775,786.22 |
| Accounts Payable |
4,897,906,817.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
332,130,629.89 |
| Taxes Payable |
180,755,746.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
150,092,472.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
122,937,601.10 |
| Other Current Liabilities |
6,231,658.90 |
| Sub-Total of Current Liabilities |
8,849,538,839.07 |
| Long-term Loans |
85,464,635.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
166,077.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
706,744,950.19 |
| Deferred Income Tax Liabilities |
376,188,515.58 |
| Other Non-Current Liabilities |
1,914,750.00 |
| Sub-Total of Non-Current Liabilities |
1,708,940,979.99 |
| Total Liabilities |
10,558,479,819.06 |
| Paid-In Capital(Or Share Stock) |
814,095,508.00 |
| Capital Surplus |
3,870,115,353.66 |
| Surplus Reserve |
407,567,099.81 |
| LESS:Treasury Stock |
5,031,777.31 |
| Undistributed Profits |
5,675,986,339.42 |
| Minority Stockholder's Interest |
1,632,334,946.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,290,415,087.80 |
| Owner's Equity（Stockholder's Equity） |
12,922,750,034.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,481,229,853.55 |
